Role of limited whole-body PET/CT in pediatric lymphoma

American Journal of Roentgenology

Volumn 196, Issue 5, 2011, Pages 1047-1055

  Sammer, Marla B K ^a,b   Shulkin, Barry L ^c   Alessio, Adam ^a   Parisi, Marguerite T ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b TC Thompson Children's Hospital   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Limited whole body imaging; Lymphoma; Pediatrics; PET CT; True whole body imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ARTICLE; CANCER STAGING; CHILD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PEDIATRIC LYMPHOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; WHOLE BODY PET; ADULT; COMPUTER ASSISTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; REPRODUCIBILITY; WHOLE BODY IMAGING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 79959580726     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.6074     Document Type: Article

References (38)

1. Kleis M, Daldrup-Link H, Matthay K, et al. Diagnostic value of PET/CT for the staging and restaging of pediatric tumors. Eur J Nucl Med Mol Imaging 2009; 36:23-36
2. Hudson MM, Krasin MJ, Kaste SC. PET imaging in pediatric Hodgkin's lymphoma. Pediatr Radiol 2004; 34:190-198 (Pubitemid 38396972)
3. Riad R, Omar W, Kotb M, et al. Role of PET/CT in malignant pediatric lymphoma. Eur J Nucl Med Mol Imaging 2010; 37:319-329
4. McCarville B. The role of positron emission tomography in pediatric musculoskeletal oncology. Skeletal Radiol 2006; 35:553-554 (Pubitemid 43983959)
5. Franzius C, Juergens KU, Vormoor J. PET/CT with diagnostic CT in the evaluation of childhood sarcoma. (letter) AJR 2006; 186:581; author reply, 581-582
6. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med 2009; 50:1237-1243
7. 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 2008; 35:1581-1588
8. 18F-FDG PET/CT 1.0. J Nucl Med 2006; 47:885-895
9. Shammas A, Lim R, Charron M. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions. RadioGraphics 2009; 29:1467-1486
10. Rosenberg SA, Kaplan HS. Evidence for an orderly progression in the spread of Hodgkin's disease. Cancer Res 1966; 26:1225-1231
11. Plaza JA, Perez-Montiel D, Mayerson J, Morrison C, Suster S. Metastases to soft tissue: a review of 118 cases over a 30-year period. Cancer 2008; 112:193-203
12. Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101:3875-3876 (Pubitemid 36857861)
13. Tsukamoto N, Kojima M, Hasegawa M, et al. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. Cancer 2007; 110:652-659 (Pubitemid 47106156)
14. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25:571-578 (Pubitemid 350002965)
15. Karam M, Novak L, Cyriac J, Ali A, Nazeer T, Nugent F. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer 2006; 107:175-183 (Pubitemid 43939045)
16. Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood 2007; 110:3507-3516 (Pubitemid 350159614)
17. 18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol 2001; 12:825-830
18. Teras M, Tolvanen T, Johansson JJ, Williams JJ, Knuuti J. Performance of the new generation of whole-body PET/CT scanners: Discovery STE and Discovery VCT. Eur J Nucl Med Mol Imaging 2007; 34:1683-1692 (Pubitemid 47476933)
19. Alessio AM, Kinahan PE, Manchanda V, Ghioni V, Aldape L, Parisi MT. Weight-based, low-dose pediatric whole-body PET/CT protocols. J Nucl Med 2009; 50:1570-1577
20. Bolard G, Prior JO, Modolo L, et al. Performance comparison of two commercial BGO-based PET/CT scanners using NEMA NU 2-2001. Med Phys 2007; 34:2708-2717 (Pubitemid 47019793)
21. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31:1860-1861
22. Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. Cancer Treat Rep 1977; 61:1023-1027
23. Shrimpton PC, Jones DG. Normalised organ doses for x ray computed tomography calculated using Monte Carlo techniques and a mathematical anthropomorphic phantom. Radiat Prot Dosimetry 1993; 49:241-243 (Pubitemid 23331379)
24. CT dosimetry tool [computer program]. Impactscan.org Website. St. George's Healthcare NHS Trust, 2007. www.impactscan.org/ctdosimetry.htm. Accessed February 23, 2011
25. Valentin J, ed. The 2007 Recommendations of the International Commission on Radiological Protection: ICRP publication 103. International Commission on Radiological Protection Website. www.icrp.org/docs/ICRP-Publication-103-Annals- of-the-ICRP-37(2-4)-Free-extract.pdf. Published March 2007. Accessed February 23, 2011
26. Nguyen NC, Chaar BT, Osman MM. Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT. BMC Med Imaging 2007; 7:8
27. Brenner DJ, Hall EJ. Computed tomography: an increasing source of radiation exposure. N Engl J Med 2007; 357:2277-2284 (Pubitemid 350190758)
28. Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology. Br J Radiol 2008; 81:362-378 (Pubitemid 351743850)
29. Chodick G, Ronckers CM, Shalev V, Ron E. Excess lifetime cancer mortality risk attributable to radiation exposure from computed tomography examinations in children. Isr Med Assoc J 2007; 9:584-587 (Pubitemid 47323412)
30. Brenner DJ. Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatr Radiol 2002; 32:228-231; discussion, 242-244
31. Chawla S, Federman N, Nagata K, et al. Estimated cumulative radiation dose from PET/CT in pediatric patients with malignancies: a 5-year retrospective review. (abstr) Pediatr Radiol 2008; 38[suppl]:S339
32. Gelfand MJ, Sharp SE, Treves ST, Fahey FH, Parisi MT, Alessio AM. Estimated cumulative radiation dose from PET/CT in children with malignancies. (letter) Pediatr Radiol 2010; 40:1712-1713; author reply, 1714-1715
33. Voss SD, Reaman GH, Kaste SC, Slovis TL. The ALARA concept in pediatric oncology. Pediatr Radiol 2009; 39:1142-1146
34. Warbey VS, Schleyer PJ, Barrington SF, O'Doherty MJ. The new EANM paediatric dosage card: does it conform to ALARA for PET/CT? Eur J Nucl Med Mol Imaging 2007; 34:1881-1882 (Pubitemid 47599067)
35. Cote CJ, Wilson S. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: an update. Paediatr Anaesth 2008; 18:9-10
36. Mellon RD, Simone AF, Rappaport BA. Use of anesthetic agents in neonates and young children. Anesth Analg 2007; 104:509-520
37. Treves ST, Davis RT, Fahey FH. Administered radiopharmaceutical doses in children: a survey of 13 pediatric hospitals in North America. J Nucl Med 2008; 49:1024-1027 (Pubitemid 351793445)
38. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1. Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8:727-737 (Pubitemid 27397895)